Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 김재상 | * |
| dc.date.accessioned | 2025-10-27T16:30:02Z | - |
| dc.date.available | 2025-10-27T16:30:02Z | - |
| dc.date.issued | 2025 | * |
| dc.identifier.issn | 0925-4439 | * |
| dc.identifier.other | OAK-37974 | * |
| dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/273143 | - |
| dc.description.abstract | Accelerated cholesterol and lipid metabolism are hallmarks of non-small cell lung cancer (NSCLC). Recently, epidermal growth factor receptor (EGFR) signaling has been shown to regulate de novo cholesterol synthesis and low-density lipoprotein receptor (LDLR) expression through SREBP-1-dependent pathways. This suggests that targeting EGFR signaling in cholesterol metabolism might provide a new therapeutic strategy for NSCLC. In this study, we demonstrated that AX-0085, a small-molecule drug, significantly inhibits EGFR kinase activity and subsequently suppresses cholesterol and lipid metabolism in NSCLC. Transcriptomic analysis showed that cholesterol and lipid metabolism-related transcripts were significantly downregulated in AX-0085-treated NSCLC cells compared to the mock control. In addition, AX-0085 downregulates EGF signaling-dependent SREBP1-mediated cholesterol biosynthesis-related enzymes and LDLR in NSCLC. Moreover, AX-0085 dramatically reduced proliferation, colony-forming ability, and migration in NSCLC cells by blocking EGFR signaling. Furthermore, treatment with AX-0085 decreased both tumor size and volume in the LLC-xenograft model. These results demonstrate that AX-0085 effectively suppresses cholesterol metabolism in NSCLC cells by inhibiting EGF-mediated SREBP1 signaling, suggesting a potential therapeutic strategy targeting cholesterol metabolism in NSCLC. © 2025 Elsevier B.V. | * |
| dc.description.sponsorship | Elsevier B.V. | * |
| dc.language | English | * |
| dc.subject | Cholesterol biosynthesis | * |
| dc.subject | Epidermal growth factor receptor | * |
| dc.subject | Kinase activity | * |
| dc.subject | Lipid uptake | * |
| dc.subject | Low-density lipoprotein receptor | * |
| dc.subject | Non-small cell lung cancer | * |
| dc.subject | Tumor growth | * |
| dc.title | EGFR inhibitor suppresses tumor growth by blocking lipid uptake and cholesterol synthesis in non-small cell lung cancer | * |
| dc.type | Article | * |
| dc.relation.issue | 7 | * |
| dc.relation.volume | 1871 | * |
| dc.relation.index | SCIE | * |
| dc.relation.index | SCOPUS | * |
| dc.relation.journaltitle | Biochimica et Biophysica Acta - Molecular Basis of Disease | * |
| dc.identifier.doi | 10.1016/j.bbadis.2025.167957 | * |
| dc.identifier.wosid | WOS:001523312100001 | * |
| dc.identifier.scopusid | 2-s2.0-105008814558 | * |
| dc.author.google | Rhie B.-H. | * |
| dc.author.google | Woo S.H. | * |
| dc.author.google | Kim H.-Y. | * |
| dc.author.google | Karapurkar J.K. | * |
| dc.author.google | Jo W.-J. | * |
| dc.author.google | Kim J. | * |
| dc.author.google | Kim D.H. | * |
| dc.author.google | Choi M.J. | * |
| dc.author.google | Park Y.J. | * |
| dc.author.google | Hong Y. | * |
| dc.author.google | Hong S.-H. | * |
| dc.author.google | Ramakrishna S. | * |
| dc.author.google | Kim K.-S. | * |
| dc.contributor.scopusid | 김재상(8643335800) | * |
| dc.date.modifydate | 20260618111230 | * |